LB-1Treatment with Oral ALS-008176, a Nucleoside Analog, Rapidly Reduces RSV Viral Load and Clinical Disease Severity in a Healthy Volunteer Challenge Study

@inproceedings{DeVincenzo2014LB1TreatmentWO,
  title={LB-1Treatment with Oral ALS-008176, a Nucleoside Analog, Rapidly Reduces RSV Viral Load and Clinical Disease Severity in a Healthy Volunteer Challenge Study},
  author={John P DeVincenzo and Hosnieh Fathi and Matthew McClure and Christopher E. Westland and S. Chanda and Rob Lambkin-Williams and Patrick F. Smith and Lisa Harrison and J. Symons and Cecilia Scaglioni-Weinlich and Qingling Zhang and Keith A Nieforth and Leo Beigelman and Lawrence Mitchell Blatt and John Fry},
  year={2014}
}

Similar Papers

Loading similar papers…